Everest Medicines Announces Regulatory Update and Strategic Partnership for Xeravaâ„¢ in Taiwan
- Written by PR Newswire
Taiwan FDA accepts New Drug Application for Xerava for treatment of cIAI
Everest enters into strategic partnership with TTY Biopharm for the commercialization of Xerava in Taiwan
SHANGHAI, Aug. 11, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing...














